Advertisement

“Bisphenol a: an emerging threat to male fertility”

  • Federica CariatiEmail author
  • Nadja D’Uonno
  • Francesca Borrillo
  • Stefania Iervolino
  • Giacomo Galdiero
  • Rossella Tomaiuolo
Open Access
Review
Part of the following topical collections:
  1. The influence of environment and lifestyle on human fertility

Abstract

Background

Among the factors causing male infertility, one of the most debated is the exposure to environmental contaminants. Recently, the chemical compound Bisphenol A (BPA) has drawn attention from the reproductive science community, due to its ubiquitous presence in day-to-day life. Its toxic action appears to mainly affect the male reproductive system, directly impacting male fertility.

Main

The purpose of this review is to investigate current research data on BPA, providing an overview of the findings obtained from studies in animal and human models, as well as on its supposed mechanisms of action.

Conclusion

A clear understanding of BPA action mechanisms, as well as the presumed risks deriving from its exposure, is becoming crucial to preserve male fertility. The development and validation of methodologies to detect BPA toxic effects on reproductive organs can provide greater awareness of the potential threat that this chemical represents.

Keywords

Bisphenol a Male fertility Endocrine disrupting compounds 

Abbreviations

17-OH-PREG

17α-hydroxypregnenolone

AhR

Aryl hydrocarbon receptor

AR

Androgen receptor

BPA

Bisphenol A

DHEA

5-dehydroepiandrosterone

DHT

5α-dihydrotestosterone

EDC

Endocrine disruptors and reproductive health

ER

Estrogen receptor

ERK

Extracellular signal-regulated kinases

FAI

Free androgen index

FSH

Follicle stimulating hormone

GnRH

Gonadotropin-releasing hormone

GPER

Associated G protein-coupled estrogen receptor

ICSI

Intracytoplasmic cell injection

IGF-I

Insulin-like growth factor

INHB

Inhibin B

IVF

In vitro fertilization

LH

Luteinizing hormone

LHRH

Luteinizing hormone releasing hormone

NCoR

Nuclear receptor co-repressor

PREG

Pregnenolone

PXR

Pregnane X receptor

SHBG

Sex hormone binding globulin

SMRT

Silencing mediator for thyroid hormone receptors

Bisphenol A (BPA) is used in industry, especially in polycarbonate plastics manufacturing processes and food packaging [1]. BPA is a crystalline chemical compound with formula C15H16O2 and a structure made of two hydroxyphenyl groups, which give to it a mild phenolic odour. BPA-based polycarbonate plastics are exceptionally strong and stable as they can endure exposure to high temperatures and sustain high-impact collisions. These characteristics make them valuable as components of safety equipment and food containers as they withstand heating in microwave ovens. Being a component of epoxy resins in protective coatings, such as those lining the inner surfaces of cans, BPA helps to extend the shelf life of food and beverage products. Indeed, one of the first studies aimed at quantifying BPA leaching from food containers showed that the chemical is present at a range of 4-23 μg per can [2]. The resiliency of BPA plastics has led to their use in medical devices such as heart-lung machines, incubators, hemodialyzers, and dental sealants and fillers; also, their light weight and optical clarity has made them especially useful for eyeglasses. Furthermore, BPA is found in a variety of other products, including compact discs and paper receipts.

Due to his widespread applications, the use of BPA has garnered increasing attention over the last decade, especially in terms of human safety. It has been estimated that levels of conjugates of BPA in urine are above safety thresholds in 90% of individuals tested in several population studies [3].

Unconjugated BPA, in its aglycone form, was shown to bind estrogen receptors, resulting in a weak estrogenic activity [4, 5]. At the same time, experimental studies in animal models reported BPA ability to bind to androgen receptors (AR), along with other metabolic regulators as thyroid hormone receptors [6]. Due to these results, more attention has been recently focused on BPA toxic effects on the reproductive system [7]. Although scientific data obtained from wildlife and in vivo studies in animal models show the negative effects of BPA on reproductive fitness, there is a growing body of literature investigating the disrupting effects of BPA on male reproductive system, which however presents heterogeneous and sometimes conflicting results between animal and human. This review intends to gather scientific data about the BPA effects on the male reproductive system and the most appropriate analytical strategy. In this review, the effects of BPA on animal and human reproduction and on the hypothalamic-pituitary-gonadal axis will be presented and discussed.

Mechanisms of BPA as reproductive toxicity

Based on observed evidence from in vitro and in vivo studies, different hypotheses were postulated about the mechanisms through which BPA exerts its toxic effects on reproductive system. In particular, BPA is commonly considered to have estrogenic and antiandrogenic effects able to disrupt the hypothalamic-pituitary-gonadal axis, and the ability to alter normal epigenetic patterns with impairing consequences on the reproductive system.

The processes of gonadotropin-releasing hormone (GnRH) release, gonadotropins secretion, and signalling trigger for spermatogonial cell proliferation in Sertoli cells, can all be affected by BPA action [8]. Gonadotropin levels alteration, in particular a decrease of LH serum concentration, induces a reduction in testosterone production by Leydig cells. Commonly, testosterone is converted to DHT and is responsible for spermatogenesis, transport and storage of spermatozoa prior to ejaculation through the epididymis. Furthermore, testosterone, after its conversion to estradiol by aromatase, maintains Sertoli’s cells functions. Consequently, low testosterone levels and alteration of estradiol catabolism result in high levels of estradiol, which compromise sperm production as demonstrated in young rats treated with high doses of estrogens [9].

It is known that estrogen receptors (ER) are expressed in Leydig cells (ERα), whereas ERβ receptors are expressed in Sertoli cells, pachytene spermatocytes and round spermatidis of the adult rat and male testis. Molecular studies have reported that BPA is a selective ER modulator, which means that it acts as an estrogen agonist in some tissues and an estrogen antagonist in others [10]. In vitro studies have demonstrated that BPA binding to estrogen receptors alters their ability to recruit tissue-specific co-activators important for differential tissue-dependent responses [11, 12]. In addition, it has been demonstrated that BPA has chemical affinity for a membrane-associated G protein-coupled estrogen receptor (GPER), equivalent to its primary ligand, estradiol. By binding to the GPER receptor, which expression has also been identified in the hypothalamus and pituitary, BPA can induce rapid, non-genomic effects [13].

According to previous data, an in vivo study in the adult rat showed that low doses of BPA can induce strong, membrane-initiated estrogenic effects, indicating that the exposure to low levels of this compound might interfere with normal estrogenic signalling pathway [14].

In vivo studies on Wistar rats, performed at different developmental stages, showed that BPA estrogenic effect results in the inhibition of testicular steroidogenesis, leading to hypogonadotropic hypogonadism with development of defective reproductive tracts [15, 16].

Research on BPA antiandrogenic activity has produced controversial data. Chemical substances with antiandrogenic properties are able to modulate male reproductive functions by inhibiting the binding of androgens to AR and subsequently down-regulate androgen-induced gene expression. Most of antiandrogenic chemicals contain at least an aromatic ring with a hydroxyl group (-OH). In the case of BPA, the –OH on the A-phenyl ring is essential for the inhibitory effect on the AR [17]. In vitro studies showed that, following treatment with BPA, the inhibition of AR is partial and it lacks of a dose-response relationship, suggesting a non-competitive mechanism [18]. Contrary, an another in vitro study, showed that BPA is able to block the androgen receptor-mediated gene expression competing with DHT to bind AR, revealing a significant inhibitory effect on the DHT-induced transcriptional activity [19].

Recent data instead showed BPA as an androgen receptor antagonist, preventing endogenous androgens from regulating androgen-dependent transcription and inhibiting Sertoli cell proliferation [20]. The mechanism operates by blocking the amino- and carboxyl-terminal regions (AR N/C) of the AR and enhancing the interactions of AR with silencing mediator for thyroid hormone receptors (SMRT) and nuclear receptor co-repressor (NCoR) [20].

Finally, several in vitro studies suggested that epigenetic alterations might occur following BPA exposure, causing adverse effects of on male reproductive system, including lowering semen quality. Atkinson and colleagues showed that bisphenol o-quinone, a reactive metabolite of BPA, is able to bind DNA by covalent bonds and in the presence of peroxidase activation system also produced toxic adducts [21]. Formation of DNA adducts in sexual tissues throughout organogenesis can cause genetic imbalance, gene modifications and chromosomal mutations with permanent effects [22]. Current studies also suggest that early exposures to BPA could lead to late onset modifications that could be inherited throughout generations by epigenetic mechanisms, such as methylation-meditated promoter silencing [11].

According to in vitro studies, Manikkam and colleagues showed that methylation levels of long interspersed nucleotide elements, which is used as a marker of genome-wide methylation status, is significantly lower in human sperm of BPA-exposed workers compared to unexposed controls [23].

BPA and male reproduction in animal models

The toxic effect of BPA on the male reproductive functions is well defined in animals model and demonstrated by physiological changes throughout foetal, pubertal and adult life of male rats (Table 1) [15, 24, 25]. In addition several in vitro studies were performed to elucidate the mechanisms through which BPA is able to modify the endocrine response, the effect of steroid hormones as well as spermatogenesis.
Table 1

Bisphenol-A and Male Reproduction in Animal Models

↓ decrease, ↑ increase, T Testosterone, IGF Insuline-like Grow Factor, GnRH Gonadotropin Releasing Hormone

It is proven that developing embryos are more vulnerable to environmental contaminants than the adult animals [26]. The extensive evidence, reported above, that BPA exerts estrogenic activity and the possibility that even a low exposure during foetal life could have a toxic effect at several physiological levels is under debate [15].

Several studies confirm that mice treated with BPA, even at low dosage, during the foetal life show persistent effects on tissues of male reproductive organs, structural and neurological changes as well as alteration of androgens functions that play a fundamental role in male sex differentiation and development of the male phenotype [27, 28, 29].

In particular, male mice exposed to BPA during the preimplantation period (days 1–5 of gestation), showed a reduction of serum and testicular testosterone levels when euthanized at 24 postnatal days and an increase of GnRH mRNA at 35 and 50 postnatal days [30]. In addition, retardation of testicular development with a reduction of seminiferous tubules’ diameter and epithelium height in BPA-exposed mice (35 postnatal days) and a scanty spermatogenesis in terms of numbers of spermatogenic cells (50 postnatal days) was detected. Finally, a decrease in expression of testicular StAR (responsible for cholesterol transport to the inner mitochondrial membrane), and a reduction of histone acetylation of the StAR gene promoter, was observed in BPA-exposed mice at 35 and 50 postnatal days [30].

Recently, an in vivo study in pregnant mice exposed to BPA on embryonic days 7 to 14 showed testis morphological alteration with a reduction in the number of stage VIII seminiferous epithelial cells and a decrease of sperm count, motility parameters, and intracellular ATP levels in offspring mice analysed at postnatal day 120 [31]. In addition, this study showed a decrease of protein kinase A (PKA) activity and tyrosine phosphorylation in spermatozoa (essential proteins for ATP generation and oxidative stress response).

Contrary, female rats treated with Bisphenol AF (1,1,1,3,3,3-hexafluoro-2,2-bis(4-hydroxyphenyl) propane, BPAF), an analogue of BPA, during gestational and lactation period showed a significant increase of testosterone levels and significant decrease of inhibin B (INHB) levels in offspring’s testis [28]. Moreover, using RNA-seq analysis, BPAF was shown to alter the expression of 279 genes in the testis of pups exposed to BPA both in prenatal and postnatal stages. Especially, expression alteration was detected for those genes involved in G2/M checkpoint, cell differentiation, cell cycle, G2/M transition, and DNA recombination [28]. Specifically, in disaccord with previously mentioned study, these experiments showed that BPAF was able to increase the transcription of StAR, and mRNA levels of ERa and AR. In addition, testes of male rats exposed to BPAF exhibited increased protein levels of genes involved in steroidogenesis (P450scc and StAR) compared to those in the control group [28].

Studies in pubertal male rats showed that exposure to BPA determines an increase of plasma LH after LHRH injection and a reduction of plasma testosterone levels, with a consequent decrease of epididymal sperm count. In addition, an enlarged ventral prostate gland and an increase of plasma IGF-I were observed in BPA-treated rats [29]. The toxic effect of BPA on spermatogenesis is probably due to its ability to perturb the integrity of the blood-testis barrier; in vitro studies on Sertoli cells showed an association between exposure to BPA, ERK pathway activation, a decline in the levels of specific tight junctions proteins, basal ectoplasmic specialization and blood-testis barrier gap junctions [29].

BPA chemical toxic effects are confirmed in adult rats, showing reduced testes and prostate gland weights, decreased serum testosterone levels, reduced diameter and thickness of seminiferous tubules, significantly thinner seminiferous epithelium and subsequent abnormal spermatogenesis in term of decreased sperm count and motility [25]. The authors postulate that in rats exposed to BPA there is a loss of structural integration in the gonadal compartment with the formation of gaps between germinal cells, as demonstrated previously in in vitro studies [32, 33].

Studies focused on the effect of BPA on spermatogenesis revealed a reduction of type A spermatogonia, spermatocytes and spermatids and an inhibition of spermiation, characterized by an increase in stage VII and a decrease in stage VIII of the seminiferous epithelium cycle [34, 35]. In an in vivo study by Jin and colleagues, low dosages of BPA were given to rats via oral administration; results show an impairment of spermatogenesis caused by the reduction of reproductive hormones serum level (FSH, LH, GnRH) and stopping germ cells meiosis process, thus activating the apoptosis pathway in germ cells [35]. In details, BPA administration reduces testosterone biosynthesis and secretion, thus inhibiting the activity of GnRH neurons, and lowering the expression of steroidogenic enzymes. Consequently, a decline of testosterone levels and a reduction in spermatozoa concentration was seen.

Another study, male chicks treated with oral administration of BPA in low doses for more than 23 weeks resulted in developmental arrest and reduced weight of the testes, which showed smaller seminiferous tubules defective spermatogenesis [36].

Additionally, levels of malondialdehyde and superoxide dismutase and decreased levels of glutathione peroxidase were found increased in the liver of BPA-treated rats compared to the control group. This observation leads to the hypothesis that BPA also induces antioxidants depletion and oxidative stress in epididymal sperm [25]. As a result, BPA disrupts the rapid movement of sperm through the epididymis, ultimately compromising its function. Moreover, the oxidative stress caused by BPA alters cellular metabolism, depleting ATP metabolism, affecting the intermediate piece functions and ultimately decreasing spermatozoa motility and velocity [37]. BPA administration in animals was also found associated to significant DNA fragmentation in sperm cells [37]. Additionally, a recent study by D’Cruz et al. suggests that BPA ability of inducing oxidative stress and estrogenic activity may also perturb glucose homeostasis in testes [38].

BPA and male reproduction in humans

Few studies have investigated BPA exposure in relation to male reproduction in humans, and results are discordant (Table 2).
Table 2

Bisphenol A and Male Reproduction in Humans

↓ decrease, ↑ increase, T Testosterone, LH Luteinizing Hormone, E2 Estradiol, FAI Free Androgen Index, SHBG Sex Hormone Binding Hormone, E1 estrone, E3 estriol, PREG Pregnenolone, DHEA 5-dehydroepiandrosterone, DHT 5a-dihydrotestosterone

An epidemiological study on 218 men showed that men exposed to BPA in the workplace have an increased risk for compromised semen quality compared to men not exposed to BPA. In particular, an increasing urinary BPA level was significantly associated with the decrease of sperm concentration, total sperm count, sperm vitality and motility [39]. In addition, authors showed a dose-response relationship between increasing urine BPA levels and reduction in semen quality in men with low BPA exposure as well as in those with high BPA exposure at the workplace. [39].

Interestingly, Lassen and colleagues, in order to evaluate a possible effect on reproductive hormones as well as semen quality, measured BPA concentration in 308 Danish young men who attended a compulsory physical examination for military service. Authors found urine BPA detectable in 98% of men and an increase of the concentration of serum testosterone, luteinizing hormone (LH), estradiol and free testosterone in BPA dose-dependent manner. In addition, men in the highest quartile of BPA also had significantly lower percentage progressive motile spermatozoa compared with men in the lowest quartile [40]. In contrast with previous study, Lassen at al didn’t found any association between BPA and other semen parameters.

Goldston et al. in a similar population study, 501 males at reproductive age, didn’t find any association between BPA and conventional semen parameters [41]. However, despite the enlarged population study, the semen analysis was performed automatically by CASA system 24 h after collection resulting in a difficult comparison with clinical outcome. Therefore the study is not directly comparable with clinical assessments.

Instead, a study on 375 fertile men, partners of pregnant women, exposed to low environmental BPA levels has shown a significant inverse association between urinary BPA concentration and free androgen index (FAI) levels, as well as a significant positive association between BPA and the sex hormone binding globulin (SHBG) [42]. No significant associations were found between any semen parameters and urinary BPA concentration [42].

On the other hand, BPA in men with impaired fertility appears to alter hormones levels with detriment of semen parameters. Men with different degrees of fertility, classified as slightly (oligospermic, asthenospermic and oligoasthenospermic men), moderately (teratospermic, oligoasthenoteratospermic and oligoteratospermic men) and severely infertile men (azoospermic men), have shown a negative association between seminal BPA levels (but not BPA plasma levels) and sperm concentration, total sperm count and morphology [43, 44]. In addition, hormone measurements have shown a different correlation between plasma and seminal BPA. Specifically, plasma BPA levels were found positively correlated with steroids levels at early stages of hormone biosynthesis (PREG, 17-OH-PREG and DHEA), negatively associated with di 5α-dihydrotestosterone (DHT) and positively associated with estradiol (E2) and estrone (E1). Contrary to plasma associations, seminal BPA levels appear to be negatively associated with steroids levels. Similarly, seminal BPA concentrations were positively correlated with E2 and estriol (E3]. The evident divergence and, sometimes, opposed association between steroids and BPA in both fluids plasma and seminal suggests that their composition is significantly different [44].

Finally, infertile and fertile men from metropolitan, urban and rural Italian areas were enrolled in a study to the investigated BPA levels and expression of nuclear receptors (ERα, ERβ, AR, PXR and AhR). A significant difference was reported in metropolitan areas where infertile men had significantly higher levels of BPA compared to fertile men [45]. In addition, gene expression analysis showed that men from metropolitan areas had higher expression levels of nuclear receptors compared to subjects from other areas. Expression ERα, ERβ, AR, AhR and PXR genes was positively correlated with BPA levels, suggesting their possible use as biomarkers for BPA intoxication.

In addition, an association between BPA urinary concentration and an increase in sperm DNA damage measured as the percentage of DNA in comet tail was found [46]. DNA structure alteration could be attributed to the induction of oxidative stress and depletion of antioxidant defence mechanisms. In an in vitro study by Barbonetti and colleagues, human spermatozoa were exposed to different levels of BPA, starting from concentration of 300 μM. The researchers found that BPA can affect sperm integrity even at low concentrations, due to the formation of pro-oxidants and apoptosis triggered by mitochondrial dysfunction [47]. Exposure to BPA was also associated with an increased mitochondrial generation of superoxide anion, caspase-3 and caspase-9 activation and a sperm motility decline [47]. Importantly, it is well documented that sperm DNA damage is associated to decreased sperm count and increased sperm aneuploidy rates and subsequently associated to atypical telomere lengths (essential for the maintenance of chromosome stability). One of the consequences of paternal genome instability is the disruption of sperm functionality [48]. In support to this hypothesis, clinical data showed that patients with semen samples affected by all of these alterations didn’t produce viable pregnancies. In fact, the demonstrated toxic effect of BPA on semen quality raises the question about potential adverse effects during embryo development. In a study by Knez and colleagues on 149 couples undergoing IVF or intracytoplasmic sperm injection (ICSI) procedures, an association between urinary BPA concentration in the male partner and lower sperm count and concentration was identified. However, no negative effects on embryo development parameters from oocyte fertilization to the blastocyst formation stage were detected [49].

Discussion

This review focused on BPA toxicity on the reproductive system, focusing on its antiestrogenic and antiandrogenic effects. Especially, experimental evidence and conflicting data about the effect of BPA on male reproduction in animal model and in humans were pointed out. Despite some controversial data, it is clear that BPA-mediated alteration of endogenous steroids levels occurs at different stages as they enter synthesis, metabolism, distribution or clearance processes. BPA can also interact directly with steroid receptors to either simulate or block steroid actions [50, 51]. The majority animal studies, performed at different developmental stages, showed that BPA estrogenic effect results in testis morphological alteration, testicular steroidogenesis inhibition, leading to hypogonadotropic hypogonadism and compromised spermatogenesis. On the other hand, discordant data were reported about the role of BPA in humans. Inconsistency of results regarding BPA effects on semen quality could be due to intrinsic differences in population sampling across the various studies. In fact, all studies reviewed in this article have sampling biases as they analyse men exposed to BPA but with no proven fertility [39], young men not exposed to BPA and with no proven fertility [40] and fertile men from the general population exposed to BPA [42].

In addition, differences in concentrations of individual steroids and BPA across human body fluids were shown by several studies explained above. In particular, concentrations were measured with different methods, introducing potential biases in the analysis and consequently affecting clinical significance. Probably, the development of a method able to measure both steroids and BPA in a single run would deliver more accurate results, as shown for estrogens and BPA by LC–MS/MS assay [52]. In particular, this study found that BPA and steroids concentration differed between seminal fluid and blood plasma. The results of this validation method confirmed that there is a transfer of BPA from blood to seminal plasma through blood–testis barrier, as previously indicated in in vitro studies.

Conclusion

A clear understanding of BPA action mechanisms, as well as of the presumed risks deriving from its exposure, is becoming crucial to preserve male fertility. In order to improve the weight-of-evidence about BPA effects, large population studies aimed to analyse semen parameters, steroid hormone levels and molecular variations of fertile and infertile men is needed as outlined in Fig. 1. In order to properly evaluate BPA toxic effect on reproductive organs, it will be crucial that future studies follow World Health Organization guidelines for semen analysis and employ the most accurate method to measure BPA concentration in seminal fluid.
Fig. 1

Flowchart of studies on Bisphenol-A and Male Reproduction in Humans

Notes

Acknowledgements

Not applicable.

Funding

Not applicable.

Availability of data and materials

Literature research results are available from the authors on reasonable request.

Authors’ contributions

FC conceived the idea and wrote the manuscript. ND was involved in manuscript drafting. FB, SI and GD were involved in data acquisition and figures generation. RT approved the final manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and have approved submission.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Shelby MD. NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. NTP CERHR MON. 2008;v, vii-ix.Google Scholar
  2. 2.
    Brotons JA, Olea-Serrano MF, Villalobos M, Olea N. Xenoestrogens released from lacquer coating in food cans. Environ Health Perspect. 1994;103:608–12.CrossRefGoogle Scholar
  3. 3.
    Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol a (BPA). Reprod Toxicol. 2007;24:139–77.CrossRefGoogle Scholar
  4. 4.
    Gould JC, Leonard LS, Maness SC, Wagner BL, Conner K, Zacharewski T, et al. Bisphenol a interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol Cell Endocrinol. 1998;142:203–14.CrossRefGoogle Scholar
  5. 5.
    Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252–63.CrossRefGoogle Scholar
  6. 6.
    Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, et al. In vivo effects of bisphenol a in laboratory rodent studies. Reprod Toxicol. 2007;24:199–224.CrossRefGoogle Scholar
  7. 7.
    Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive health: The case of bisphenol-A. Mol Cell Endocrinol. 2006;254–255:179–86.Google Scholar
  8. 8.
    Chimento A, Sirianni R, Casaburi I, Pezzi V. Role of estrogen receptors and g protein-coupled estrogen receptor in regulation of hypothalamus-pituitary-testis axis and spermatogenesis. Front Endocrinol. 2014;5:1.Google Scholar
  9. 9.
    Pinto ME. Vilamaior PS. Góes RM. Exposure of young rats to high estrogen doses leads to degeneration of elongated spermatids. Tissue Cell: Taboga SR; 2008.Google Scholar
  10. 10.
    Wersinger SR, Haisenleder DJ, Lubahn DB, Rissman EF. Steroid feedback on gonadotropin release and pituitary gonadotropin subunit mRNA in mice lacking a functional estrogen receptor alpha. Endocrine. 1999;11:137–43.CrossRefGoogle Scholar
  11. 11.
    Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadaf A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. In vitro molecular mechanisms of bisphenol a action. Reproductive Toxicol. 2007;24:178–98.CrossRefGoogle Scholar
  12. 12.
    Routledge EJ, White R, Parker MG, Sumpter JP. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ER beta. J Biol Chem. 2000;275:35986–93.CrossRefGoogle Scholar
  13. 13.
    Alonso M, Ropero AB, Soriano S, García-Arévalo M, Ripoll C, Fuentes E, Quesada I, Nadal Á. Bisphenol-a acts as a potent estrogen via non-classical estrogen triggered pathways. Mol Cell Endocrinol. 2012;355:201–7.CrossRefGoogle Scholar
  14. 14.
    Sakaue M, Ohsako S, Ishimura R, Kurosawa S, Kurohmaru M, Hayashi Y, Aoki Y, Yonemoto J, Tohyama C. Bisphenol-a affects spermatogenesis in the adult rat even at low dose. J Occup Health. 2001;43:185–90.CrossRefGoogle Scholar
  15. 15.
    Vom Saal FS. Triennial reproduction symposium: environmental programming of reproduction during fetal life: effects of intrauterine position and the endocrine disrupting chemical bisphenol a. J Animal Sci. 2016;94:2722–36.CrossRefGoogle Scholar
  16. 16.
    Wisniewski P, Romano RM, Kizys MM, Oliveira KC, Kasamatsu T, Giannocco G, Chiamolera MI, Dias-da-Silva MR, Romano MA. Adult exposure to bisphenol a (BPA) in Wistar rats reduces sperm quality with disruption of the hypothalamic-pituitary-testicular axis. Toxicology. 2015;329:1–9.CrossRefGoogle Scholar
  17. 17.
    Xu LC, Sun H, Chen JF, Bian Q, Qian J, Song L, Wang XR. Evaluation of androgen receptor transcriptional activities of bisphenol a, octylphenol and nonylphenol in vitro. Toxicology. 2005;216:197–203.CrossRefGoogle Scholar
  18. 18.
    Lee HJ, Chattopadhyay S, Gong EY, Ahn RS, Lee K. Antiandrogenic effects of bisphenol a and nonylphenol on the function of androgen receptor. Toxicol Sci. 2003;75:40–6.CrossRefGoogle Scholar
  19. 19.
    Sun H, Xu LC, Chen JF, Song L, Wang XR. Effect of bisphenol a, tetrachlorobisphenol a and pentachlorophenol on the transcriptional activities of androgen receptor-mediated reporter gene. Food Chem Toxicol. 2006;44:1916–21.CrossRefGoogle Scholar
  20. 20.
    Wang H, Ding Z, MeiShi Q, Ge WHX, Li MX, Chen G, Wang Q, Ju Q, Zhang JP, Zhang MR, Xu LC. Anti-androgenic mechanisms of bisphenol a involve androgen receptor signaling pathway. Toxicology. 2017;387:10–6.CrossRefGoogle Scholar
  21. 21.
    Atkinson A, Roy D. In vitro conversion of environmental estrogenic chemical bisphenol a to DNA binding metabolite(s). Biochem Biophys Res Commun. 1995;210:424–33.CrossRefGoogle Scholar
  22. 22.
    Jonathan N, Steinmets R. Xenoestrogens: the emerging story of bisphenol a. Trends Endocrinol Metab. 1998;9:124–8.CrossRefGoogle Scholar
  23. 23.
    Miao M, Zhou X, Li Y, Zhang O, Zhou Z, Li T, Yuana W, Li R, Li DK. LINE-1 hypomethylation in spermatozoa is associated with bisphenol a exposure. Andrology. 2014;2:138–44.CrossRefGoogle Scholar
  24. 24.
    Herath CB, Jin W, Watanabe G, Arai K, Suzuki AK, Taya K. Adverse effects of environmental toxicants, Octylphenol and bisphenol a, on male reproductive functions in pubertal rats. Endocrine. 2004;25:163–72.CrossRefGoogle Scholar
  25. 25.
    Kourouma A, Peng D, Chao Q, Lopez YM, Changjiang L, Chengmin W, Wenjuan F, Suqin Q, Tingting Y, Kedi Y. Bisphenol a induced reactive oxygen species (ROS) in the liver and affect epididymal semenv quality in adults Sprague-Dawley rats. J Toxicol Environ Health Sci. 2014.  https://doi.org/10.5897/JTEHS2014.0309.
  26. 26.
    Ikezuki Y, Tsutsumi O, Takai Y, Kamei Y, Taketani Y. Determination of bisphenol a concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod. 2002;17:2839–41.CrossRefGoogle Scholar
  27. 27.
    Kawai K, Nozaki T, Nishikata H, Aou S, Takii M, Kubo C. Aggressive behavior and serum testosterone concentration during the maturation process of male mice: the effects of fetal exposure to bisphenol a. Enviro Health Perspect. 2003;111:175–8.CrossRefGoogle Scholar
  28. 28.
    Li J, Sheng N, Cui R, Feng Y, Shao B, Guo X, Zhang H, Dai J. Gestational and lactational exposure to bisphenol AF in maternal rats increases testosterone levels in 23-day-old male offspring. Chemosphere. 2016;163:552–61.CrossRefGoogle Scholar
  29. 29.
    Li MW, Mruk DD, Lee WM, Cheng CY. Disruption of the blood-testis barrier integrity by bisphenol a in vitro: is this a suitable model for studying blood-testis barrier dynamics? Int J Biochem Cell Biol. 2009;41:2302–14.CrossRefGoogle Scholar
  30. 30.
    Hong J, Chen F, Wang X, Bai Y, Zhou R, Li Y, Chen L. Exposure of preimplantation embryos to low-dose bisphenol a impairs testes development and suppresses histone acetylation of StAR promoter to reduce production of testosterone in mice. Mol Cell Endocrinol. 2016;427:101–11.CrossRefGoogle Scholar
  31. 31.
    Rahman MS, Kwon WS, Karmakar PC, Yoon SJ, Ryu BY, Pang MG. Gestational exposure to bisphenol a affects the function and proteome profile of F1 spermatozoa in adult mice. Environ Health Perspect. 2017;125:238–45.CrossRefGoogle Scholar
  32. 32.
    Kazemi S, Bahramifar N, Moghadamnia AA, Jorsarae SG. Detection of bisphenol a and Nonylphenol in Rat's blood serum, tissue and impact on reproductive system. Electron Physician. 2016;8:2772–80.CrossRefGoogle Scholar
  33. 33.
    Kazemi S, Feizi F, Aghapour F, Joorsaraee GA, Moghadamnia AA. Histopathology and Histomorphometric investigation of bisphenol a and Nonylphenol on the male rat reproductive system. N Am J Med Sci. 2016;8:215–21.CrossRefGoogle Scholar
  34. 34.
    Liu XL, Chen XY, Wang ZC, Shen T, Zhao H. Effects of exposure to bisphenol a during pregnancy and lactation on the testicular morphology and caspase-3 protein expression of ICR pups. Biomed Rep. 2013;1:420–4.CrossRefGoogle Scholar
  35. 35.
    Jin P, Wang X, Chang F, Bai Y, Li Y, Zhou R, Chen L. Low dose bisphenol a impairs spermatogenesis by suppressing reproductive hormone production and promoting germ cell apoptosis in adult rats. J Biomed Res. 2013;27:135–44.PubMedGoogle Scholar
  36. 36.
    Furuya M, Adachi K, Kuwahara S, Ogawa K, Tsukamoto Y. Inhibition of male chick phenotypes and spermatogenesis by bisphenol-a. Life Sci. 2006;78:1767–76.CrossRefGoogle Scholar
  37. 37.
    Hulak M, Gazo I, Shaliutina A, Linhartova P. In vitro effects of BPA on the quality parameters, oxidative stress, DNA integrity and adenosine triphosphate content in sterlet (Acipenser ruthenus) spermatozoa. Comp Biochem Physiol. 2013;158:64–71.Google Scholar
  38. 38.
    D’Cruz SC1, Jubendradass R, Mathur PP. Bisphenol A induces oxidative stress and decreases levels of insulin receptor substrate 2 and glucose transporter 8 in rat testis. Reprod Sci. 2012; 2:163–72.Google Scholar
  39. 39.
    Li DK1, Zhou Z, Miao M, He Y, Wang J, Ferber J, Herrinton LJ, Gao E, Yuan W. Urine bisphenol-A (BPA) level in relation to semen quality. Fertil Steril. 2011;95:625–30.e1–4.Google Scholar
  40. 40.
    Lassen TH, Frederiksen H, Jensen TK, Petersen JH, Joensen UN, Main KM, Skakkebaek EN, Juul A, Jørgensen N, Andersson A. Urinary bisphenol a levels in young men: association with reproductive hormones and semen quality. Environ Health Perspect. 2014;122:478–84.CrossRefGoogle Scholar
  41. 41.
    Goldstone AE, Chen Z, Perry MJ, Kannan K, Germaine M. Urinary bisphenol a and semen quality. The LIFE Study Reprod Toxicol. 2015;51:7–13.CrossRefGoogle Scholar
  42. 42.
    Mendiola J, Jørgensen N, Andersson AM, Calafat A, Ye X, Bruce JR, Drobnis EZ, Wang C, Sparks A, Thurston SW, Liu F, Swan SH. Are environmental levels of bisphenol a associated with reproductive function in fertile men? Environ Health Perspect. 2010;118:1286–91.CrossRefGoogle Scholar
  43. 43.
    Vitku J, Sosvorova L, Chlupacova T, Hampl R, Hill M, Sobotka V, Heracek J, Bicikova M, Starka L. Differences in Bispheno a and estrogen levels in the plasma and seminal plasma of men with different degrees of infertility. Physiol Res. 2015;64(Suppl 2):S303–11.PubMedGoogle Scholar
  44. 44.
    Vitku J, Heracek J, Sosvorova L, Hampl R, Chlupacova T, Hill M, Sobotka V, Bicikova M, Starka L. Associations of bisphenol A and polychlorinated biphenyls with spermatogenesis and steroidogenesis in two biological fluids from men attending an infertility clinic. Environ Int. 2016;89–90:166–73.Google Scholar
  45. 45.
    La Rocca C, Tait S, Guerranti C, Busani L, Ciardo F, Bergamasco B, Perra G, Mancini FR, Marci R, Bordi G, Caserta D, Focardi S, Moscarini M, Mantovani M. Exposure to endocrine disruptors and nuclear receptors gene expression in infertile and fertile men from Italian areas with different environmental features. Int J Environ Res Public Health. 2015;12:12426–45.CrossRefGoogle Scholar
  46. 46.
    Meeker JD, Ehrlich S, Toth TL, Wright DL, Calafat AM, Trisini AT, Ye X, Hauser R. Semen quality and sperm DNA damage in relation to urinary bisphenol a among men from an infertility clinic. Reprod Toxicol. 2010;30:532–9.CrossRefGoogle Scholar
  47. 47.
    Barbonetti A, Castellini C, Di Giammarco N, Santilli G, Francavilla S, Francavilla F. In vitro exposure of human spermatozoa to BPA induces pro-oxidative/apoptotic mitochondrial dysfunction. Reproductive Toxicol. 2016;66:61–7.CrossRefGoogle Scholar
  48. 48.
    Cariati F, Jaroudi S, Alfarawati S, Raberi A, Alviggi C, Pivonello R, Wells D. Investigation of sperm telomere length as a potential marker of paternal genome integrity and semen quality. Reprod BioMed Online. 2016;33:404–11.CrossRefGoogle Scholar
  49. 49.
    Knez J, Kranvogl R, Breznik BP, Voncina E, Vlaisavljevi V. Are urinary bisphenol a levels in men related to semen quality and embryo development after medically assisted reproduction? Fertil Steril. 2014;101:215–21.CrossRefGoogle Scholar
  50. 50.
    Labohá P, Jambor T, Yawer A, Lukáč N, Sovadinová I. Molecular mechanisms of alkylphenol-mediated endocrine disruption in Leydig cells. Toxicol Lett. 2016;258:245–6.  https://doi.org/10.1016/j.toxlet.2016.06.1872.CrossRefGoogle Scholar
  51. 51.
    Gaido KW, Maness SC, McDnnell DP, Dehal SS, Kupfer D, Safe S. Interaction of methoxychlor and related compounds with estrogen receptor alpha and beta, and androgen receptor: structure-activity studies. Mol Pharmacol. 2000;58:852–8.CrossRefGoogle Scholar
  52. 52.
    Vitku J, Chlupacova T, Sosvorova L, Hampl R, Hill M, Heracek J, Bicikova M, Starka L. Development and validation of LC–MS/MS method for quantification of bisphenol a and estrogens in human plasma and seminal fluid. Talanta. 2015;140:62–7.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Federica Cariati
    • 1
    • 2
    • 3
    Email author
  • Nadja D’Uonno
    • 2
  • Francesca Borrillo
    • 1
    • 2
  • Stefania Iervolino
    • 3
  • Giacomo Galdiero
    • 4
  • Rossella Tomaiuolo
    • 1
    • 2
    • 3
  1. 1.Dipartimento di Medicina Molecolare e Biotecnologie MedicheUniversità degli Studi di Napoli Federico IINaplesItaly
  2. 2.CEINGE-Biotecnologie Avanzate s.c.a r.l.NaplesItaly
  3. 3.KronosDNA s.r.l., Spin-off Università degli Studi di Napoli Federico IINaplesItaly
  4. 4.Dipartimento di Medicina Clinica e ChirurgiaUniversità degli Studi di Napoli Federico IINaplesItaly

Personalised recommendations